Retavase

Indicated For

acute ST-elevation myocardial infarction (STEMI)

About This Medication

# Retavase Patient Assistance Program Guide: How to Get Retavase at Low or No Cost **Important Notice: Retavase (reteplase) currently has no dedicated manufacturer-sponsored patient assistance program (PAP).** This guide provides general steps for accessing financial help for this emergency thrombolytic drug used to treat acute ST-elevation myocardial infarction (STEMI), a severe type of heart attack. Retavase works by dissolving blood clots in heart arteries to reduce risks of death and heart failure[2][4][5]. Given the lack of a specific PAP and past drug shortage issues[1], explore alternatives like hospital billing assistance, state programs, or generic options if available. Always consult your doctor or hospital social worker immediately, as Retavase is administered intravenously in hospitals during emergencies[4][5]. ## About Retavase Retavase is a recombinant tissue plasminogen activator (tPA) that breaks down blood clots by converting plasminogen to plasmin, which degrades the fibrin in thrombi[2][5][7]. It's indicated for acute STEMI to improve blood flow and outcomes, given as two 10-unit IV doses 30 minutes apart, ideally soon after symptoms start[2][5]. It's not for children and has risks like bleeding, stroke, or allergic reactions—contraindicated in active bleeding, recent stroke, or uncontrolled hypertension[2][3]. **This is a hospital-administered drug, not for home use.** Patient education from sources like MSKCC emphasizes monitoring for bleeding and informing all providers[3]. ## Who Qualifies for Assistance? Without a specific PAP, eligibility falls under general pharmaceutical aid programs, hospital charity care, or government resources. Common criteria for similar PAPs include: - **US residency** and valid prescription. - **Uninsured, underinsured, or high copays.** - **Income at or below 400-500% of the Federal Poverty Level (FPL), though exact thresholds vary.** Since Retavase details are unavailable, check **NeedyMeds.org**, **RxAssist.org**, or **Partnership for Prescription Assistance (PPARx.org)** for updates. Hospitals often cover emergency STEMI treatments via indigent care policies. ## Income Eligibility Breakdown No specific Retavase PAP income limits exist. For reference, typical PAPs use these **2026 FPL-based thresholds** (estimated; verify current HHS guidelines): | Household Size | 400% FPL (Common Threshold) | 500% FPL (Higher Threshold) | |----------------|-----------------------------|-----------------------------| | Individual | ~$60,000 | ~$75,000 | | Couple | ~$81,000 | ~$101,000 | | Family of 3 | ~$102,000 | ~$127,000 | | Family of 4 | ~$123,000 | ~$154,000 | *Notes: Add ~$21,000 per additional member for 400% FPL. Some programs exclude assets or have state variations. Medicare patients may qualify separately.* ## Insurance Requirements Retavase is typically covered by Medicare Part B (hospital outpatient) or commercial insurance for emergencies, but high deductibles apply. **No PAP if you have insurance** is common—programs target uninsured/underinsured. Medicare enrollees often can't use manufacturer PAPs but can use Extra Help or state pharmaceutical aid (SPAPs). Confirm with your hospital billing department[3]. ## Step-by-Step Application Process 1. **Ask your cardiologist or hospital social worker** post-STEMI treatment about Retavase costs (vial ~$2,600)[7]. 2. **Search aggregator sites:** Visit RxAssist.org, NeedyMeds.org, or PPARx.org; search "reteplase" or "Retavase." 3. **Contact manufacturer remnants:** Past makers include EKR Therapeutics (acquired by Cornerstone)[1]; call general assistance lines like 1-888-4PPA-NOW. 4. **Apply for hospital charity care:** Submit income proof to hospital financial aid office. 5. **Government options:** Apply for Medicaid retroactively or state aid. 6. **Mail/fax general PAP apps** if found, including proof of income/residency. ## Timeline and Delivery Processing for general aid: 2-4 weeks, but emergencies may get expedited hospital help. Delivery: Direct to hospital pharmacy, not home, as Retavase requires IV administration by professionals[5]. Expect free or discounted vials if approved. ## Alternatives if Denied - **Hospital financial assistance** or payment plans. - **Patient Access Network (PAN) Foundation** or HealthWell for heart conditions. - **State pharmaceutical assistance** (e.g., California's CA APP). - **Generic tPA alternatives** like alteplase (tPA), though Retavase showed better flow in trials[5]. No biosimilars listed. - **Clinical trials** via ClinicalTrials.gov for STEMI. ## Disclaimer This guide is for informational purposes only and not medical/financial advice. Retavase PAP details are unavailable as of 2026; drug is discontinued in some forms [1][3]. Costs, availability, and eligibility change—verify with healthcare providers. Bleeding risks are serious; follow doctor instructions[2][3]. Consult professionals for personalized help. Word count: 912.

Program information last verified: March 30, 2026